文献速递关节外科

真性红细胞增多症增加初次全关节置换术后并发症风险:6932例回顾性匹配对照研究

Does Polycythemia Vera Increase Risk of Postoperative Complications Following Primary Total Joint Arthroplasty? A Retrospective Matched Control Cohort Study of 6932 Polycythemia Vera Patients.
PubMed 文献 · J Arthroplasty · 2019-11-04

基于Medicare数据库的回顾性匹配对照研究纳入6932例真性红细胞增多症(PV)患者,其中4643例行全膝关节置换(TKA)、2289例行全髋关节置换(THA),并与匹配对照组比较。PV与TKA后急性肺栓塞、深静脉血栓、术后血肿和手术部位感染风险升高相关,也与THA后急性肺栓塞、深静脉血栓、术后血肿和1年死亡率升高相关。

要点

  • PV患者TKA后急性PE、DVT、术后血肿和SSI风险显著高于匹配对照。
  • PV患者THA后急性PE、DVT、术后血肿和1年死亡率显著高于匹配对照。
  • PV患者行初次全关节置换术前应重视血栓栓塞及出血并发症风险。

核心结论

  • PV与初次全关节置换术后DVT、PE、术后血肿风险升高显著相关。
  • PV与TKA后SSI风险升高显著相关,与THA后1年死亡率升高显著相关。

研究设计与样本

  • 回顾性Medicare数据库匹配对照队列研究,纳入2006至2013年6932例PV患者,其中TKA 4643例、THA 2289例,并设各自匹配对照组。

主要发现

  • TKA后PV组急性PE发生率2.3% vs 1.6%(OR 1.44,95%CI 1.17-1.75),DVT 4.2% vs 3.6%(OR 1.40,95%CI 1.20-1.61,P < .001)。
  • TKA后PV组术后血肿发生率0.6% vs 0.4%(OR 1.57,95%CI 1.03-2.28),SSI 4.5% vs 3.6%(OR 1.25,95%CI 1.08-1.44,P = .002)。
  • THA后PV组急性PE发生率1.9% vs 1.4%(OR 1.40,95%CI 1.01-1.88,P = .035),DVT 3.5% vs 2.6%(OR 1.32,95%CI 1.04-1.66,P = .035)。
  • THA后PV组术后血肿发生率1.1% vs 0.6%(OR 1.86,95%CI 1.22-2.80),1年死亡率2.2% vs 1.6%(OR 1.43,95%CI 1.06-1.89,P = .016)。

临床怎么用

  • 对PV患者行初次TKA或THA前,应充分评估并告知血栓栓塞、出血及感染等并发症风险。
  • 术后需加强PV患者的血栓与出血监测,TKA后关注SSI,THA后关注1年死亡风险。

局限性

  • 本研究为回顾性数据库研究,可能存在编码偏倚和未控制混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is sparsity of data on outcomes following joint arthroplasty among polycythemia vera (PV) patients. The aim of this study is to evaluate postoperative outcomes following primary total knee (TKA) and hip (THA) arthroplasty among PV patients. METHODS: A retrospective Medicare database review identified 6932 PV patients who underwent a primary total joint arthroplasty (4643 TKAs and 2289 THAs) from 2006 to 2013. A comparison of hospital length of stay, mortality, and the diagnosis of surgical site infections (SSIs), stroke, myocardial infarction, acute pulmonary embolism (PE), deep vein thrombosis (DVT), and other postoperative complications was made between PV patients undergoing TKA and THA and their respective matched control groups. RESULTS: PV was significantly associated with increased rates of acute PE (2.3% vs 1.6%; odds ratio [OR] 1.44, 95% confidence interval [CI] 1.17-1.75), DVT (4.2% vs 3.6%; OR 1.40, 95% CI 1.20-1.61, P < .001), postoperative hematoma (0.6% vs 0.4%; OR 1.57, 95% CI 1.03-2.28), and SSI (4.5% vs 3.6%; OR 1.25, 95% CI 1.08-1.44, P = .002) following TKA. Among PV patients who underwent a primary THA, PV was significantly associated with increased rate of acute PE (1.9% vs 1.4%; OR 1.40, 95% CI 1.01-1.88, P = .035), DVT (3.5% vs 2.6%; OR 1.32, 95% CI 1.04-1.66, P = .035), postoperative hematoma (1.1% vs 0.6%; OR 1.86, 95% CI 1.22-2.80), and 1-year mortality (2.2% vs 1.6%; OR 1.43, 95% CI 1.06-1.89, P = .016). CONCLUSION: PV was significantly associated with increased risk for DVT, PE, postoperative hematoma, SSI (TKA only), and 1-year mortality (THA only) following primary total joint arthroplasty.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Labaran LA, Amin R, Sequeira S, et al. Does Polycythemia Vera Increase Risk of Postoperative Complications Following Primary Total Joint Arthroplasty? A Retrospective Matched Control Cohort Study of 6932 Polycythemia Vera Patients. J Arthroplasty. 2019. PMID: 31776052. doi:10.1016/j.arth.2019.10.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。